Toll-like receptors, tissue injury, and tumourigenesis

Mediators of Inflammation

Volumn 2010, Issue , 2010, Pages

  Voulgarelis, Michael ^a   Ioannou, Savvas ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR;

APOPTOSIS; CANCER CELL; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER RESISTANCE; CARCINOGENESIS; HUMAN; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TISSUE INJURY; WOUND HEALING;

ANIMALS; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; IMMUNITY, INNATE; IMMUNOTHERAPY; INFLAMMATION; MYELOID DIFFERENTIATION FACTOR 88; NEOPLASMS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TUMOR MICROENVIRONMENT;

EID: 77957832280     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2010/581837     Document Type: Review

References (68)

1. Takeda K., Kaisho T., Akira S., Toll-like receptors Annual Review of Immunology 2003 21 335 376
2. Picker L. J., Butcher E. C., Physiological and molecular mechanisms of lymphocyte homing Annual Review of Immunology 1992 10 561 591
3. Blander J. M., Medzhitov R., Regulation of phagosome maturation by signals from Toll-like receptors Science 2004 304 5673 1014 1018
4. Schnare M., Barton G. M., Holt A. C., Takeda K., Akira S., Medzhitov R., Toll-like receptors control activation of adaptive immune responses Nature Immunology 2001 2 10 947 950 (Pubitemid 32976167)
5. Tsan M.-F., Toll-like receptors, inflammation and cancer Seminars in Cancer Biology 2006 16 1 32 37
6. Hansson G. K., Edfeldt K., Toll to be paid at the gateway to the vessel wall Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 6 1085 1087
7. Akira S., Takeda K., Toll-like receptor signalling Nature Reviews Immunology 2004 4 7 499 511
8. El-Omar E. M., Ng M. T., Hold G. L., Polymorphisms in Toll-like receptor genes and risk of cancer Oncogene 2008 27 2 244 252
9. Chochi K., Ichikura T., Kinoshita M., Majima T., Shinomiya N., H., Kawabata T., Sugasawa H., Ono S., Seki S., Mochizuki H., Helicobacter pylori augments growth of gastric cancers via the lipopolysaccharide-toll-like receptor 4 pathway whereas Its lipopolysaccharide attenuates antitumor activities of human mononuclear cells Clinical Cancer Research 2008 14 10 2909 2917
10. Jelavi T. B., Barii M., Hofman I. D., Boraska V., Vrdoljak E., Peruzovi M., Hozo I., Puljiz., Terzi J., Microsatellite GT polymorphism in the toll-like receptor 2 is associated with colorectal cancer Clinical Genetics 2006 70 2 156 160
11. Tahara T., Arisawa T., Wang F., Shibata T., Nakamura M., Sakata M., Hirata I., Nakano H., Toll-like receptor 2-196 to 174del polymorphism influences the susceptibility of Japanese people to gastric cancer Cancer Science 2007 98 11 1790 1794
12. Nieters A., Beckmann L., Deeg E., Becker N., Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk Genes and Immunity 2006 7 8 615 624
13. Zhou X.-X., Jia W.-H., Shen G.-P., Qin H.-D., Yu X.-J., Chen L.-Z., Feng Q.-S., Shugart Y. Y., Zeng Y.-X., Sequence variants in toll-like receptor 10 are associated with nasopharyngeal carcinoma risk Cancer Epidemiology Biomarkers and Prevention 2006 15 5 862 866
14. Stevens V. L., Hsing A. W., Talbot J. T., Zheng S. L., Sun J., Chen J., Thun M. J., Xu J., Calle E. E., Rodriguez C., Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk International Journal of Cancer 2008 123 11 2644 2650
15. Janeway C. A. Jr., Medzhitov R., Innate immune recognition Annual Review of Immunology 2002 20 197 216
16. Tsan M.-F., Gao B., Endogenous ligands of Toll-like receptors Journal of Leukocyte Biology 2004 76 3 514 519
17. Miyake K., Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors Seminars in Immunology 2007 19 1 3 10
18. Lee M. S., Kim Y.-J., Signaling pathways downstream of pattern-recognition receptors and their cross talk Annual Review of Biochemistry 2007 76 447 480
19. Re F., Strominger J. L., Heterogeneity of TLR-induced responses in dendritic cells: from innate to adaptive immunity Immunobiology 2004 209 1-2 191 198
20. McDermott E. P., O'Neill L. A. J., Ras participates in the activation of p38 MAPK by interleukin-1 by associating with IRAK, IRAK2, TRAF6, and TAK-1 The Journal of Biological Chemistry 2002 277 10 7808 7815
21. Nyirenda M. H., O'Brien K., Sanvito L., Constantinescu C. S., Gran B., Modulation of regulatory T cells in health and disease: role of toll-like receptors Inflammation and AllergyDrug Targets 2009 8 2 124 129
22. Milkova L., Voelcker V., Forstreuter I., The NF-kappaB signaling pathway is involved in the LPS/IL-2-induced upregulation of FoxP3 expression in human CD4CD25 regulatory T cells. Experimental Dermatology. In press
23. Macedo L., Pinhal-Enfield G., Alshits V., Elson G., Cronstein B. N., Leibovich S. J., Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors American Journal of Pathology 2007 171 6 1774 1788
24. Jiang D., Liang J., Fan J., Yu S., Chen S., Luo Y., Prestwich G. D., Mascarenhas M. M., Garg H. G., Quinn D. A., Homer R. J., Goldstein D. R., Bucala R., Lee P. J., Medzhitov R., Noble P. W., Regulation of lung injury and repair by Toll-like receptors and hyaluronan Nature Medicine 2005 11 11 1173 1179
25. Tsung A., Sahai R., Tanaka H., Nakao A., Fink M. P., Lotze M. T., Yang H., Li J., Tracey K. J., Geller D. A., Billiar T. R., The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion Journal of Experimental Medicine 2005 201 7 1135 1143
26. Oyama J.-I., Blais C. Jr., Liu X., Pu M., Kobzik L., Kelly R. A., Bourcier T., Reduced myocardial ischemia-reperfusion injury in Toll-like receptor 4-deficient mice Circulation 2004 109 6 784 789
27. Tsung A., Zheng N., Jeyabalan G., Izuishi K., Klune J. R., Geller D. A., Lotze M. T., Lu L., Billiar T. R., Increasing numbers of hepatic dendritic cells promote HMGB1-mediated ischemia-reperfusion injury Journal of Leukocyte Biology 2007 81 1 119 128
28. Colletti L. M., Remick D. G., Burtch G. D., Kunkel S. L., Strieter R. M., Campbell D. A. Jr., Role of tumor necrosis factor- in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat Journal of Clinical Investigation 1990 85 6 1936 1943
29. Rdiger H. A., Clavien P., Tumor necrosis factor, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver Gastroenterology 2002 122 1 202 210
30. Fukata M., Chen A., Klepper A., Krishnareddy S., Vamadevan A. S., Thomas L. S., Xu R., Inoue H., Arditi M., Dannenberg A. J., Abreu M. T., Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: role in proliferation and apoptosis in the intestine Gastroenterology 2006 131 3 862 877
31. Pai R., Soreghan B., Szabo I. L., Pavelka M., Baatar D., Tarnawski A. S., Prostaglandin E 2, transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy Nature Medicine 2002 8 3 289 293
32. Ramanathan M., Pinhal-Enfield G., Hao I., Leibovich S. J., Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter Molecular Biology of the Cell 2007 18 1 14 23
33. Seki E., De Minicis S., sterreicher C. H., Kluwe J., Osawa Y., Brenner D. A., Schwabe R. F., TLR4 enhances TGF- signaling and hepatic fibrosis Nature Medicine 2007 13 11 1324 1332
34. Paik Y.-H., Schwabe R. F., Bataller R., Russo M. P., Jobin C., Brenner D. A., Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells Hepatology 2003 37 5 1043 1055
35. Paik Y.-H., Lee K. S., Lee H. J., Yang K. M., Lee S. J., Lee D. K., Han K.-H., Chon C. Y., Lee S. I., Moon Y. M., Brenner D. A., Hepatic stellate cells primed with cytokines upregulate inflammation in response to peptidoglycan or lipoteichoic acid Laboratory Investigation 2006 86 7 676 686
36. Ghosh S., Karin M., Missing pieces in the NF- B puzzle Cell 2002 109, supplement S81 S96
37. Becker I., Salaiza N., Aguirre M., Delgado J., Carrillo-Carrasco N., Kobeh L. G., Ruiz A., Cervantes R., Torres A. P., Cabrera N., Gonzlez A., Maldonado C., Isibasi A., Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2 Molecular and Biochemical Parasitology 2003 130 2 65 74
38. Huang B., Zhao J., Li H., He K.-L., Chen Y., Mayer L., Unkeless J. C., Xiong H., Toll-like receptors on tumor cells facilitate evasion of immune surveillance Cancer Research 2005 65 12 5009 5014
39. Kelly M. G., Alvero A. B., Chen R., Silasi D.-A., Abrahams V. M., Chan S., Visintin I., Rutherford T., Mor G., TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer Cancer Research 2006 66 7 3859 3868
40. Huang B., Zhao J., Shen S., Li H., He K.-L., Shen G.-X., Mayer L., Unkeless J., Li D., Yuan Y., Zhang G.-M., Xiong H., Feng Z.-H., Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling Cancer Research 2007 67 9 4346 4352
41. He W., Liu Q., Wang L., Chen W., Li N., Cao X., TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance Molecular Immunology 2007 44 11 2850 2859
42. Nakanishi C., Toi M., Nuclear factor- B inhibitors as sensitizers to anticancer drugs Nature Reviews Cancer 2005 5 4 297 309
43. Kreuz S., Siegmund D., Rumpf J.-J., Samel D., Leverkus M., Janssen O., Hcker G., Dittrich-Breiholz O., Kracht M., Scheurich P., Wajant H., NF B activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP Journal of Cell Biology 2004 166 3 369 380
44. Fukata M., Chen A., Vamadevan A. S., Cohen J., Breglio K., Krishnareddy S., Hsu D., Xu R., Harpaz N., Dannenberg A. J., Subbaramaiah K., Cooper H. S., Itzkowitz S. H., Abreu M. T., Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors Gastroenterology 2007 133 6 1869 1881
45. Rakoff-Nahoum S., Medzhitov R., Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88 Science 2007 317 5834 124 127
46. Dvorak H. F., Tumors: wounds that do not heal: similarities between tumor stroma generation and wound healing The New England Journal of Medicine 1986 315 26 1650 1659
47. Taganov K. D., Boldin M. P., Chang K.-J., Baltimore D., NF- B-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses Proceedings of the National Academy of Sciences of the United States of America 2006 103 33 12481 12486
48. Salaun B., Coste I., Rissoan M.-C., Lebecque S. J., Renno T., TLR3 can directly trigger apoptosis in human cancer cells Journal of Immunology 2006 176 8 4894 4901
49. Gannot G., Gannot I., Vered H., Buchner A., Keisari Y., Increase in immune cell infiltration with progression of oral epithelium from hyperkeratosis to dysplasia and carcinoma British Journal of Cancer 2002 86 9 1444 1448
50. Condeelis J., Pollard J. W., Macrophages: obligate partners for tumor cell migration, invasion, and metastasis Cell 2006 124 2 263 266
51. Kim S., Takahashi H., Lin W.-W., Descargues P., Grivennikov S., Kim Y., Luo J.-L., Karin M., Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis Nature 2009 457 7225 102 106
52. Satta N., Kruithof E. K. O., Reber G., de Moerloose P., Induction of TLR2 expression by inflammatory stimuli is required for endothelial cell responses to lipopeptides Molecular Immunology 2008 46 1 145 157
53. Waugh D. J. J., Wilson C., The interleukin-8 pathway in cancer Clinical Cancer Research 2008 14 21 6735 6741
54. Wang W., Xu G.-L., Jia W.-D., Ma J.-L., Li J.-S., Ge Y.-S., Ren W.-H., Yu J.-H., Liu W.-B., Ligation of TLR2 by versican: a link between inflammation and metastasis Archives of Medical Research 2009 40 4 321 323
55. Nowotny A., Berry L. J., Antitumor effects of endotoxins Handbook of Endotoxin 1985 3 2nd Amsterdam, The Netherlands Elsevier 389 448 Cellular Biology of Endotoxin
56. Berendt M. J., North R. J., Kirstein D. P., The immunological basis of endotoxin induced tumor regression. Requirement for T cell mediated immunity Journal of Experimental Medicine 1978 148 6 1550 1559
57. Goriely S., Neurath M. F., Goldman M., How microorganisms tip the balance between interleukin-12 family members Nature Reviews Immunology 2008 8 1 81 86
58. Boullart A. C. I., Aarntzen E. H. J. G., Verdijk P., Jacobs J. F. M., Schuurhuis D. H., Benitez-Ribas D., Schreibelt G., Van De Rakt M. W. M. M., Scharenborg N. M., De Boer A., Kramer M., Figdor C. G., Punt C. J. A., Adema G. J., De Vries I. J. M., Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration Cancer Immunology, Immunotherapy 2008 57 11 1589 1597
59. Apetoh L., Ghiringhelli F., Tesniere A., Obeid M., Ortiz C., Criollo A., Mignot G., Maiuri M. C., Ullrich E., Saulnier P., Yang H., Amigorena S., Ryffel B., Barrat F. J., Saftig P., Levi F., Lidereau R., Nogues C., Mira J.-P., Chompret A., Joulin V., Clavel-Chapelon F., Bourhis J., Andr F., Delaloge S., Tursz T., Kroemer G., Zitvogel L., Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy Nature Medicine 2007 13 9 1050 1059
60. O'Connell R. M., Taganov K. D., Boldin M. P., Cheng G., Baltimore D., MicroRNA-155 is induced during the macrophage inflammatory response Proceedings of the National Academy of Sciences of the United States of America 2007 104 5 1604 1609
61. Banchereau J., Steinman R. M., Dendritic cells and the control of immunity Nature 1998 392 6673 245 252
62. Paczesny S., Ueno H., Fay J., Banchereau J., Palucka A. K., Dendritic cells as vectors for immunotherapy of cancer Seminars in Cancer Biology 2003 13 6 439 447
63. Re F., Strominger J. L., IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells Journal of Immunology 2004 173 12 7548 7555
64. Komai-Koma M., Jones L., Ogg G. S., Xu D., Liew F. Y., TLR2 is expressed activated T cells as a costimulatory receptor Proceedings of the National Academy of Sciences of the United States of America 2004 101 9 3029 3034
65. Garay R. P., Viens P., Bauer J., Normier G., Bardou M., Jeannin J.-F., Chiavaroli C., Cancer relapse under chemotherapy: why TLR2/4 receptor agonists can help European Journal of Pharmacology 2007 563 13 1 17
66. Okamoto M., Oshikawa T., Tano T., Ohe G., Furuichi S., Nishikawa H., Ahmed S. U., Akashi S., Miyake K., Takeuchi O., Akira S., Moriya Y., Marsubara S., Ryoma Y., Saito M., Sato M., Involvement of Toll-like receptor 4 signaling in interferon- production and antitumor effect by streptococcal agent OK-432 Journal of the National Cancer Institute 2003 95 4 316 326
67. Tano T., Okamoto M., Oshikawa T., Ahmed S. U., Sasai A., Sato M., Induction of apoptosis in human head and neck cancer cell lines by an active component of OK-432 through p53-independent pathway via toll-like receptor (TLR) 4 signaling Gan to Kagaku Ryoho 2005 32 11 1562 1564
68. Oldfield V., Keating G. M., Perry C. M., Imiquimod: in superficial basal cell carcinoma American Journal of Clinical Dermatology 2005 6 3 195 200